Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT04518644
Title Nilotinib, for Patients With CML-CP or CML-AP
Recruitment No longer available
Gender both
Phase Expanded access
Variant Requirements No
Sponsors Novartis Pharmaceuticals
Age Groups: adult | senior
Covered Countries

No variant requirements are available.